Literature DB >> 7505984

PSA and PAP as immunohistochemical markers in prostate cancer.

J I Epstein1.   

Abstract

This article describes the immunoreactivity of PSA and PAP in non-neoplastic and neoplastic prostate tissue. Listed are examples of cross reactivity of PSA and PAP in non-neoplastic and neoplastic tissue from other organs. The use of PSA and PAP to identify tumors of prostatic origin in different sites is also described. Finally, the diagnostic uses of immunohistochemistry for PSA and PAP in prostate biopsies and for prognostication are discussed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7505984

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  10 in total

1.  Gastric adenocarcinoma with prostatic metastasis.

Authors:  S Roshni; Tm Anoop; Tr Preethi; G Shubanshu; Al Lijeesh
Journal:  J Gastric Cancer       Date:  2014-06-30       Impact factor: 3.720

Review 2.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

Review 3.  Challenges in Transgender Healthcare: The Pathology Perspective.

Authors:  Sarika Gupta; Katherine L Imborek; Matthew D Krasowski
Journal:  Lab Med       Date:  2016-06-10

4.  Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

Authors:  A M De Marzo; A K Meeker; J I Epstein; D S Coffey
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer.

Authors:  Gerit Theil; Joanna Bialek; Christine Weiß; Felix Lindner; Paolo Fornara
Journal:  Diagnostics (Basel)       Date:  2022-02-15

6.  Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining.

Authors:  M Varma; D M Berney; B Jasani; A Rhodes
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

7.  Secondary signet ring cell carcinoma of prostate.

Authors:  Kalyan Khan; Arghya Bandyopadhyay; Mimi Gangopadhyay; Subrata Chakraborty; Pranati Bera
Journal:  Niger J Surg       Date:  2012-01

8.  A novel subtype of primary prostatic adenocarcinoma: A case report.

Authors:  Xiaoqing Yang; Chen Xu; Jianing Guo; Chunrui Yang; Yuming Yang; Ruifa Han
Journal:  Oncol Lett       Date:  2013-09-02       Impact factor: 2.967

Review 9.  Translational progress on tumor biomarkers.

Authors:  Hongwei Guo; Xiaolin Zhou; Yi Lu; Liye Xie; Qian Chen; Evan T Keller; Qian Liu; Qinghua Zhou; Jian Zhang
Journal:  Thorac Cancer       Date:  2015-07-27       Impact factor: 3.500

10.  Preferred Names, Preferred Pronouns, and Gender Identity in the Electronic Medical Record and Laboratory Information System: Is Pathology Ready?

Authors:  Katherine L Imborek; Nicole L Nisly; Michael J Hesseltine; Jana Grienke; Todd A Zikmund; Nicholas R Dreyer; John L Blau; Maia Hightower; Robert M Humble; Matthew D Krasowski
Journal:  J Pathol Inform       Date:  2017-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.